Skip to content Home / Companies / PRCT PRC
PROCEPT BioRobotics Corp (PRCT) XNAS SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Net insider buying (90d)
Latest PRCT Insider Trades
About PROCEPT BioRobotics Corp (PRCT) PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Headquarters SAN JOSE, CA
Employees 888
Listed 2021
Exchange XNAS https://www.procept-biorobotics.com SEC filings for PRCT on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market purchase 1 23,900 $498K Open-market sale 3 1,000 $28K Grant or award 24 317,321
PRCT Insider Transactions (Form 4) 51 40 Form 4 filings on record, the earliest from Oct 17, 2024, newest first. Filing history page 2 of 2.
Date Insider Transaction Security Shares Price Value Jun 10, 2025 TP Thomas M. Prescott - Director Grant or award Common Stock 1,538
Recent PRCT Form 8-K Filings 5
Recent PRCT Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Jun 8, 2026 - - - - View on EDGAR Jun 8, 2026 - - -
PRCT Insider Trading - FAQ
What is the latest insider trade for PRCT? PROCEPT BioRobotics Corp (PRCT) had 16 insider filings in the last 90 days, with the most recent on 2026-08-14. The full record for PRCT runs to 40 Form 4 filings, the earliest from 2024-10-17. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying PRCT stock? 1 insider purchase of PRCT was filed in the last 90 days, totaling $498K.
How many insiders are selling PRCT stock? 3 insider sales of PRCT were filed in the last 90 days, totaling $28K.
Where can I see PRCT SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks PRCT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow PRCT insider buys? Create a free InsiderAlpha account and press Watch on this page to add PRCT to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track PRCT insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free
Market cap $1.19B
P/E ratio -
Dividend yield -
Average volume 1.55M
52 week high $42.43
52 week low $16.67
Today's high $21.06
Today's low $20.38
Open $20.76
Volume 352.8K
Previous close $20.83
Shares outstanding 57.27M Market cap
$1.19B
888 employees
PRCT Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
95% Buying 5% Selling
1 insider purchase totaling $498K against 3 sales totaling $28K.
Most-Active PRCT Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Jun 10, 2025 TP Thomas M. Prescott - Director Grant or award Stock Option (Right to Buy) 2,771 $0.00 -
Jun 10, 2025 FM Frederic H. Moll - Director Grant or award Stock Option (Right to Buy) 2,771 $0.00 -
Dec 4, 2024 RZ Reza Zadno - Officer Open-market sale Common Stock 5,300 $96.15 $510K
Dec 4, 2024 RZ Reza Zadno - Officer Open-market sale Common Stock 13,762 $97.01 $1.34M
Dec 4, 2024 RZ Reza Zadno - Officer Open-market sale Common Stock 5,126 $98.09 $503K
Dec 4, 2024 RZ Reza Zadno - Officer Open-market sale Common Stock 2,235 $99.04 $221K
Dec 4, 2024 AN Alaleh Nouri - Officer Option exercise Common Stock 11,838 $7.27 $86K
Dec 4, 2024 AN Alaleh Nouri - Officer Option exercise Common Stock 4,162 $34.99 $146K
Dec 4, 2024 AN Alaleh Nouri - Officer Option exercise Common Stock 12,092 $37.02 $448K
Dec 4, 2024 AN Alaleh Nouri - Officer Open-market sale Common Stock 3,787 $96.12 $364K
Dec 4, 2024 AN Alaleh Nouri - Officer Open-market sale Common Stock 16,187 $96.98 $1.57M
Dec 4, 2024 AN Alaleh Nouri - Officer Open-market sale Common Stock 8,118 $97.90 $795K
Dec 4, 2024 AN Alaleh Nouri - Officer Option exercise Stock Option (Right to Buy) 11,838 $0.00 -
Dec 4, 2024 AN Alaleh Nouri - Officer Option exercise Stock Option (Right to Buy) 4,162 $0.00 -
Dec 4, 2024 AN Alaleh Nouri - Officer Option exercise Stock Option (Right to Buy) 12,092 $0.00 -
Nov 27, 2024 RZ Reza Zadno - Officer Open-market sale Common Stock 18,144 $97.25 $1.76M
Nov 27, 2024 RZ Reza Zadno - Officer Open-market sale Common Stock 1,684 $98.00 $165K
Nov 27, 2024 RZ Reza Zadno - Officer Open-market sale Common Stock 5,189 $99.24 $515K
Nov 27, 2024 RZ Reza Zadno - Officer Open-market sale Common Stock 1,403 $99.96 $140K
Nov 20, 2024 RZ Reza Zadno - Officer Open-market sale Common Stock 10,111 $92.12 $931K
Nov 20, 2024 RZ Reza Zadno - Officer Open-market sale Common Stock 15,809 $92.82 $1.47M
Nov 20, 2024 RZ Reza Zadno - Officer Open-market sale Common Stock 500 $93.88 $47K
Nov 13, 2024 RZ Reza Zadno - Officer Open-market sale Common Stock 10,509 $92.74 $975K
Nov 13, 2024 RZ Reza Zadno - Officer Open-market sale Common Stock 2,000 $93.64 $187K
Nov 13, 2024 RZ Reza Zadno - Officer Open-market sale Common Stock 9,401 $94.95 $893K
Nov 13, 2024 RZ Reza Zadno - Officer Open-market sale Common Stock 4,510 $95.58 $431K
Nov 5, 2024 AD Antal Rohit Desai - Director Open-market sale Common Stock 7,566 $95.38 $722K
Nov 5, 2024 AD Antal Rohit Desai - Director Open-market sale Common Stock 11,756 $96.49 $1.13M
Nov 5, 2024 AD Antal Rohit Desai - Director Open-market sale Common Stock 11,487 $97.17 $1.12M
Nov 5, 2024 AD Antal Rohit Desai - Director Open-market sale Common Stock 2,191 $98.43 $216K
Nov 6, 2024 AD Antal Rohit Desai - Director Open-market sale Common Stock 9,403 $95.68 $900K
Nov 6, 2024 AD Antal Rohit Desai - Director Open-market sale Common Stock 2,678 $96.57 $259K
Nov 6, 2024 AD Antal Rohit Desai - Director Open-market sale Common Stock 17,150 $97.59 $1.67M
Nov 6, 2024 AD Antal Rohit Desai - Director Open-market sale Common Stock 3,769 $98.29 $370K
Nov 7, 2024 AD Antal Rohit Desai - Director Open-market sale Common Stock 6,992 $94.42 $660K
Nov 7, 2024 AD Antal Rohit Desai - Director Open-market sale Common Stock 16,272 $95.33 $1.55M
Nov 7, 2024 AD Antal Rohit Desai - Director Open-market sale Common Stock 10,236 $96.03 $983K
Oct 30, 2024 RZ Reza Zadno - Officer Option exercise Common Stock 288,461 $4.37 $1.26M
Oct 30, 2024 RZ Reza Zadno - Officer Open-market sale Common Stock 288,461 $91.00 $26.25M
Oct 30, 2024 RZ Reza Zadno - Officer Option exercise Stock Option (Right to Buy) 288,461 $0.00 -
Oct 15, 2024 KW Kevin Waters - Officer Option exercise Common Stock 25,000 $4.56 $114K
Oct 15, 2024 KW Kevin Waters - Officer Open-market sale Common Stock 15,959 $72.11 $1.15M
Oct 15, 2024 KW Kevin Waters - Officer Open-market sale Common Stock 8,115 $73.02 $593K
Oct 15, 2024 KW Kevin Waters - Officer Open-market sale Common Stock 926 $73.75 $68K
Oct 15, 2024 KW Kevin Waters - Officer Option exercise Stock Option (Right to Buy) 25,000 $0.00 -
$PRVA
Privia Health Group, Inc.
$SIBN
SI-BONE, Inc.
